Since 1995, Equinox Group has provided analytics to support R&D decisions at pharmaceutical firms in over 1,000 projects, assessing the potential of drugs from discovery to launch, and anywhere in between. Our validated techniques will save our clients' time and money, as well as overcome the deficiencies of traditional market research.

Our specialties include:
• Assessing the value of drugs in R&D
• Disease-area strategy
• Indication prioritization
• Supporting business development assessments
• Market access
• Patient share forecasting
• Epidemiology & patient flow modeling


We have evaluated thousands of drug profiles across hundreds of indications in oncology, immunology, rare diseases, cardio-metabolic disorders, infectious diseases, neurology, respiratory, urology, ophthalmology, and endocrine disorders. We also have tailored methods to solve the unique analytical challenges that arise in oncology and rare diseases.

Equinox Group

Org chart

Teams

Offices